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Selenomethionine Protects Mutant Tau N27A Cell from Oxidative Stress
 and Decreases Phosphorylation of Tau 
Madelin LoCicero, Dr. Wenbo Zhou, & Dr. Curt Freed
Departments of Medicine, University of Colorado, Anshutz Medical Center, Aurora, Colorado, United States of America, Wartburg West Program
Conclusion
● Decrease amount of p-tau for 
mutant tau cell at 20uM 
● Protect mutant tau cells at 
20uM and WT tau cells at 10uM 
and 20uM from oxidative stress
● Set-Met is toxic to cells at 80uM 
concentration. 
● Overall,Set-Met could be 
preventing further 
phosphorylation to continue and 
protecting cells from oxidative 
stress, but are not destroying 
aggregated tau
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Results 
 
Cellular Model
● N27A cells
■ WT and P301L mutant tau 
mutation (AD linked gene)
■ YFP tau cell line
Objectives
Determine the effect selenium 
methionine has on:
a. Decreasing hyperphosphorylation 
of tau 
b. Protecting cells from oxidative 
stress
c. Reducing aggregated tau 
Background
● Alzheimer’s Disease (AD)  is 
neurodegenerative disease 
characterized by loss of cells and 
aggregated tau  in the 
hippocampus (3,4)
■ Hyperphosphorylated tau 
causes misfolding proteins and 
forms neurofibrillary tangles (3)
● Previous research has found that 
Set-Met decreases the amount of 
phosphorylated tau at pS404 site  
within mutant and wild type 3xTg- 
AD mice (4) 
■ Selenium can be toxic 
dependent on type of cells, 
and concentration of the 
selenium (2)
Future Work 
● Testing other drugs to see it 
effect it has on phosphorylation of 
tau
■ CHIR-99021 
● Found to inhibit GSK-3A/B 
(1)
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Figure 1a. MTT Assay of N27A (n=6) after H2O2 treatment. 
Error bars represent standard error of mean. * =p<0.01. 
Comparing  0uM Set-Met w/ H2O2 and the 20uM Set-Met w/ 
H2O2, there was a significant increase of cell viability.
Figure 2.  These cells were treated for 72 hrs. Photos were taken under confocal microscope at 20x magnification. There was a 
significant change between the 0uM Set-Met w/o H2O2 treatment and 0uM Set-Met and 20uM Set-Met w/ H2O2 treatment. 
There was no significant difference between the amount of aggregated tau (green signal) between any of the treatment groups.  
Figure 1b. MTT Assay of N27A (n=6) after H2O2 treatment. 
Error bars represent standard error of mean. **** 
=p<0.0001.Comparing 0uM Set-Met w/ H2O2 with the 10uM 
and 20uM Set-Met w/ H2O2, there was a significant 
increase of cell viability.
Figure 3a. Western Blot of WT and mutant tau cell treated with 
Set-Met after 72 hrs.There was a significant difference between 
the p-tau and the amount of b-actin in the cells for the mutant 
tau cells at 20uM. 
Figure 3b. Comparison between the amount of B-actin 
protein vs. p-tau for the western blot treated with 
Set-Met. The mutant tau 20uM Set-Met had the same 
amount of p-tau as the control group, suggesting that it 
is the ideal dosage of Set-Met to reduce p-tau. 
* ****
****
Western Blot 
   Mutant Tau Mutant Tau Mutant Tau 
0uM Set-Met w/o H2O2    0uM Set-Met w/ H2O2      20uM Set-Met w/H2O2
   WT Tau                              WT Tau              WT tau 
0uM Set-Met w/o H2O2    0uM Set-Met w/ H2O2      20uM Set-Met w/H2O2
Results for Western Blot 
MTT Assay 
